National Health Commission Launches One-Year Anti-Corruption Campaign in Pharmaceutical Sector
The emergency response department of the National Health Commission (NHC) has released a notification signaling...
Policy / Regulatory
Johnson & Johnson Files Lawsuit Against US Government’s Drug Pricing Negotiation Authority
United States-based Johnson & Johnson (J&J, NYSE: JNJ) has filed a lawsuit this week, challenging...
US Merger Guidelines Updated: Public Comment Sought on Antitrust Law Changes
The United States has published an update to its merger and acquisition guidelines, seeking public...
NMPA Releases 70th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 70th batch of reference drugs for...
China’s NHC Issues Guidelines to Enhance Clinical Department Capacities for Serious Diseases
The National Health Commission (NHC) has issued a set of guidelines aimed at strengthening clinical...
NHSA Unveils 2023 Flying Inspection Plan for Medical Insurance Fund Oversigh
The National Healthcare Security Administration (NHSA) has released its 2023 Basic Medical Insurance (BMI) Fund...
Chile Expands Financial Coverage for AbbVie’s RSV Prophylaxis Synagis
Chile’s Ministry of Health (MINSAL) has announced an immediate expansion in the coverage under its...
US FDA Approves Additional Shipments of Qilu Pharmaceutical’s Cisplatin to Address Shortage
The US Food and Drug Administration (FDA) is maintaining its reliance on China-based Qilu Pharmaceutical...
NHSA’s 2022 Report: BMI Fund Income Rises 7.6%, Outgoing Expenditure Increases 2.3%
The National Healthcare Security Administration (NHSA) has released its annual statistical report for 2022, detailing...
Shanghai’s SMPA Initiates Volume-Based Procurement for National VBP Drugs in Alliance Region
Shanghai’s Sunshine Medical Procurement All-in-One (SMPA) has released a notification indicating the commencement of follow-up...
China’s NAFR Enhances Tax Benefits for Private Health Insurance Purchases
The National Administration of Financial Regulation (NAFR) in China has issued a Notification indicating that...
CDE Launches Trial Procedures for Adding Pediatric Information to Drug Inserts
The Center for Drug Evaluation (CDE) has released the “Work Procedures for Adding Children’s Drug...
NMPA Launches “Drug Standard Management Measures” to Enhance Drug Quality and Safety
The National Medical Products Administration (NMPA) has released the “Drug Standard Management Measures,” a set...
China’s MofCOM Hosts Symposium with Multinational Corporations, Promises Development Opportunities
This week, China’s Ministry of Commerce (MofCOM) convened a symposium attended by representatives from a...
CDE Releases 72nd Batch of Generic Reference Preparations with New Specifications
The Center for Drug Evaluation (CDE) has released the 72nd batch of chemical generic reference...
NHSA Unveils Updated National Reimbursement Drug List Rules for 2023
The National Healthcare Security Administration (NHSA) has released the updated rules that will govern this...
NMPA Proposes Revisions to “Drug Inspection Management Measures”, Seeks Public Feedback
The National Medical Products Administration (NMPA) has released revised provisions of the “Drug Inspection Management...
NHSA Unveils 2023 Work Plan for National Reimbursement Drug List Update
The National Healthcare Security Administration (NHSA) has released the “Work Plan for the National Reimbursement...
Shanghai’s SMPA Notification: Non-Winning Bids in VBP Round 8 Can Avoid “Higher Price” Label
Shanghai’s Sunshine Medical Procurement All-in-One (SMPA) has released a notification concerning the 8th round of...
US FDA Issues Warning Letter to Chengdu KeCheng Fine Chemicals Over Communication Failures
The US FDA’s Center for Drug Evaluation (CDE) issued a warning letter to China-based Chengdu...